UA34396C2 - Method for production of biologically active agent for normalizing physiological state of body - Google Patents

Method for production of biologically active agent for normalizing physiological state of body

Info

Publication number
UA34396C2
UA34396C2 UA2000020633A UA200020633A UA34396C2 UA 34396 C2 UA34396 C2 UA 34396C2 UA 2000020633 A UA2000020633 A UA 2000020633A UA 200020633 A UA200020633 A UA 200020633A UA 34396 C2 UA34396 C2 UA 34396C2
Authority
UA
Ukraine
Prior art keywords
production
biologically active
active agent
physiological state
raw material
Prior art date
Application number
UA2000020633A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Євгеній Михайлович Шутаєв
Евгений Михайлович Шутаев
Наталя Володимирівна Середюк
Наталья Владимировна Середюк
Original Assignee
Євгеній Михайлович Шутаєв
Евгений Михайлович Шутаев
Наталя Володимирівна Середюк
Наталья Владимировна Середюк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Євгеній Михайлович Шутаєв, Евгений Михайлович Шутаев, Наталя Володимирівна Середюк, Наталья Владимировна Середюк filed Critical Євгеній Михайлович Шутаєв
Priority to UA2000020633A priority Critical patent/UA34396C2/en
Publication of UA34396C2 publication Critical patent/UA34396C2/en

Links

Abstract

The method for production of the biologically active agent for normalizing the physiological state of the body provides for processing of the raw material of animal origin comprising the crushing of the tissue, the homogenization, the centrifugation, and the filtration followed by the isolation of the end product. The liver, the spleen, and the blood are used as the source of the raw material. The invention relates to the medical industry and the medicine, in particular to the method for production of the biologically active substances isolated from the raw material of animal origin.
UA2000020633A 2000-02-07 2000-02-07 Method for production of biologically active agent for normalizing physiological state of body UA34396C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2000020633A UA34396C2 (en) 2000-02-07 2000-02-07 Method for production of biologically active agent for normalizing physiological state of body

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2000020633A UA34396C2 (en) 2000-02-07 2000-02-07 Method for production of biologically active agent for normalizing physiological state of body

Publications (1)

Publication Number Publication Date
UA34396C2 true UA34396C2 (en) 2001-06-15

Family

ID=74197948

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000020633A UA34396C2 (en) 2000-02-07 2000-02-07 Method for production of biologically active agent for normalizing physiological state of body

Country Status (1)

Country Link
UA (1) UA34396C2 (en)

Similar Documents

Publication Publication Date Title
Kim et al. Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts
DE69836822D1 (en) Process for the treatment of capsules and dry powdered pharmaceutical formulations
JP5588474B2 (en) Composition for promoting collagen and / or hyaluronic acid production
WO2001082958A3 (en) Methods of producing membrane vesicles
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
WO2001068811A3 (en) Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material
MXPA05006940A (en) Therapeutic formulations for the treatment of beta-amyloid related diseases.
EP1872668A4 (en) Nutrient composition
YU31801A (en) Anthranilic acid amides and the use thereof as medicaments
WO2001010907A3 (en) Therapeutic polypeptides and methods for using same
MY124714A (en) Enzyme treatment
KR101685189B1 (en) The manufacturing method of collagen peptide using abalone
WO2003040183A3 (en) Compounds for the diagnosis/prevention/treatment of alzheimer's disease
JP2008056645A (en) Anti-oxidant peptide obtained by reaction of protein in enzymatically treated royal jelly with polypeptide and method for producing the same
CN104593459A (en) Low-molecular-weight polypeptide extracted from placenta
CA2392168A1 (en) Vitamin d analogues
ATE340561T1 (en) USE OF ANTISEPTICS FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE PROPHYLAXIS AND TREATMENT OF INFLAMMATION INSIDE THE HUMAN BODY
WO2015030609A1 (en) Anti-inflammatory compositions, methods and uses thereof
JP6153469B2 (en) Composition containing hydrolyzate of soy protein
UA34396C2 (en) Method for production of biologically active agent for normalizing physiological state of body
WO2001082892A3 (en) Liposomes containing active substances
MXPA06002648A (en) Milk fractions and milk preparations for treating and/or preventing cox-2 mediated diseases.
WO2000042166A3 (en) Methods and compositions for monitoring cellular processing of epitope-tagged beta-amyloid precursor protein
WO1999020291A3 (en) Pharmaceutical grade ginkgo biloba
SI1596879T1 (en) Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis